Silva, Jean Carlos Lipreri da 
; Silva, Juan Luiz Coelho da ; Vicari, Hugo Passos ; Lima, Keli Cristina de ; Rego, Eduardo Magalhães ; Traina, Fabiola ; Machado Neto, João Agostinho
Source: Hematology, Transfusion and Cell Therapy. Unidades: FM, FMRP, ICB
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, MEDULA ÓSSEA, CÉLULAS SANGUÍNEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jean Carlos Lipreri da et al. ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2023.06.004. Acesso em: 29 jun. 2024. , 2024APA
Silva, J. C. L. da, Silva, J. L. C. da, Vicari, H. P., Lima, K. C. de, Rego, E. M., Traina, F., & Machado Neto, J. A. (2024). ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina, Universidade de São Paulo. doi:https://doi.org/10.1016/j.htct.2023.06.004NLM
Silva JCL da, Silva JLC da, Vicari HP, Lima KC de, Rego EM, Traina F, Machado Neto JA. ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2024 ; 46( 1): 105-106.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.htct.2023.06.004Vancouver
Silva JCL da, Silva JLC da, Vicari HP, Lima KC de, Rego EM, Traina F, Machado Neto JA. ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2024 ; 46( 1): 105-106.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.htct.2023.06.004
